NEW YORK, NY, March 1, 2016 — Flatiron Health and West Cancer Center today announced that West Cancer Center selected OncoEMR® and OncoAnalytics® to enhance the delivery of high quality evidence-based care, support participation in alternative payment models and better manage clinical workflows.
Based in Memphis, Tennessee, West Cancer Center is a world-class comprehensive cancer center partnered with The University of Tennessee Health Science Center and Methodist Healthcare. Founded in 1979, West Cancer Center now boasts a team of more than 75 physicians and researchers across 10 clinic sites. A true leader in cancer research, West Cancer Center has a longstanding commitment to providing patients access to clinical trials, including Phase I through Phase III studies.
“We chose OncoEMR because we wanted an innovative, medical oncology, cloud-based electronic health record that could provide our clinicians with the oncology workflows and clinical pathways they need to provide high quality patient care,” said Lee Schwartzberg, MD, Executive Director, West Cancer Center.
OncoEMR and OncoAnalytics are part of the Flatiron Health OncologyCloud® software suite, which features some of the most advanced cloud-based oncology software to support the continuum of cancer care. OncoEMR is a leading cloud-based electronic health record (EHR), designed specifically for medical oncology, that offers pathways and regimen content as well as partner-supported programs and content at the point of care. OncoAnalytics is a first-of-its-kind analytics tool that unlocks data from multiple systems, allowing providers to access valuable insights spanning business, operational, clinical and financial metrics.
“We wanted a partner who could not only provide us with a technology platform to support our providers at the point of care, but also had the vision to build technology to support alternative payment models, enable future growth, and provide us detailed clinical and business intelligence.” said Erich Mounce, Chief Executive Officer, West Cancer Center.
“We are thrilled that West Cancer Center chose Flatiron Health as their healthcare technology partner to help them navigate today’s complex healthcare environment,” said Tesh Khullar, Senior Vice President, Provider Solutions, Flatiron Health. “By leveraging OncoEMR and OncoAnalytics, West Cancer Center has the resources to streamline operational efficiency and enhance the quality and value of care through insightful analytics.”
About Flatiron Health, Inc.
Flatiron Health helps the oncology community deliver better, more efficient care by powering an innovative platform to address today’s healthcare challenges. The Flatiron Health OncologyCloud™ platform includes the industry-leading electronic medical record for oncology, advanced analytics, patient portal, and integrated billing management. Backed by Google Ventures, First Round Capital, Roche and others, Flatiron's industry-first technology platform and integrated suite of products deliver comprehensive support for cancer care providers and life science companies. For more information, please visit www.flatiron.com.
About West Cancer Center
West Cancer Center delivers the best comprehensive cancer treatment in the Mid-South, delivering a complete continuum of care to more than 30,000 individuals annually. A true leader in cancer research, West Cancer Center has a longstanding commitment to providing patients access to clinical trials, including Phase I through Phase III studies. Building on the 35-year legacy of West Clinic, West Cancer Center continues to provide comprehensive, compassionate care to the Mid-South area. This commitment is strengthened through a robust partnership with Methodist Healthcare and the University of Tennessee Health Science Center. In 2014, West Cancer Center established The University of Tennessee/West Institute for Cancer Research, a 501(c)(3) dedicated to research, development of novel cancer treatments and therapies and patient care. For more information, please visit www.westcancercenter.org.